The Global Non-Invasive Biosensors Market Growth Accelerated By Rising Demand For Continuous Health Monitoring
Non-Invasive Biosensors Market |
Non-invasive biosensors play an important role in continuous health monitoring by detecting various biochemical parameters from external surfaces of the body without any invasive procedures. These biosensors can measure vital signs like blood glucose, pressure, oxygen levels and other biomarkers from the skin surface, tears or breath. With the increasing burden of chronic diseases and aging population globally, the demand for constant health monitoring with wearable and non-invasive devices is rising significantly.
The
global Non-invasive Biosensors Market is estimated to be valued at US$ 29.84 Bn in 2023 and is expected to
exhibit a CAGR of 13% over the
forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
The demand for continuous health monitoring is accelerating the growth of the
non-invasive biosensors market. These biosensors help in detecting vital signs
and biomarkers continuously without any surgical procedures involved. This
allows high-risk patients and elderly population to monitor their health in the
comfort of their own homes. With the rising prevalence of chronic diseases,
health monitoring with non-invasive biosensors improves medical intervention
and management of diseases. The ability to monitor health trends over long
periods aids in better treatment outcomes. Continuous monitoring with
biosensors enhances patient comfort and safety dramatically.
Segment Analysis
The global non-invasive biosensors market is dominated by implantable
biosensors sub-segment due to growing demand for continuous monitoring of
health parameters. Implantable biosensors help in monitoring of blood pressure,
blood glucose, hormone levels and others through minimally invasive procedures.
It has wide applications in diabetes, cancer, cardiology and neurology
treatment.
Key Takeaways
The Global
Non-Invasive Biosensors Market Size is
expected to witness high growth during the forecast period of 2023 to 2030. The
market size for 2023 is US$ 29.84 Bn and is anticipated to grow at a CAGR of
13%.
Regional analysis:
North America region currently dominates the global non-invasive biosensors
market due to developed healthcare infrastructure and availability of
technologically advanced devices. Presence of major players and higher
healthcare spending in US and Canada drives the growth of the market. Asia
Pacific region is expected to be the fastest growing market during the forecast
period due presence of huge patient population, growing medical tourism
industry and rising per capita healthcare expenditure in countries like China and
India.
Key players:
Key players operating in the non-invasive biosensors market are Intuitive
Surgical, Think Surgical, Asensus Surgical US, Inc., Zimmer Biomet, Stryker,
Smith & Nephew, Novus Health Products, and Medtronic. Intuitive Surgical
dominates the market due to its strong foothold in implantable biosensors
through partnerships with major healthcare institutes. Think Surgical is
continuously launching technologically advanced implantable biosensors for
minimally invasive surgeries.
Get
more insights on this topic:
Comments
Post a Comment